drugset / Trial / NCT05705414
Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis
Phase 0
Recruiting
28 enrolled
The University of Texas Health Science Center at San Antonio
IIMS-UT Health San Antonio · collabNational Center for Advancing Translational Sciences (NCATS) · collab
RandomizedCrossoverOpen-labelTreatment
Summary
The study will test and compare the efficacy of a single essential amino acid valine with a combination of essential amino acids (EAA) supplement on fatigue, frailty, and cognitive function in end-stage kidney disease (ESKD) patients undergoing hemodialysis (HD) treatment.
Timeline
- Start
- 2024-10-18
- Primary completion
- 2026-06
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EEA | Other / unclassified | 12.5 g | Oral |
| Subject | valine | Other / unclassified | 8 g | Oral |